Robert J Donnelly

Title: Innovations of Robert J Donnelly

Introduction

Robert J Donnelly is a notable inventor based in Fords, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of cell-penetrating peptides and their applications in therapeutic delivery systems. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

Donnelly's latest patents include "Glutamate-enhanced cell-penetrating peptides and methods of using same." This invention discloses novel glutamate-enhanced cell-penetrating peptides (CPPs) designed to serve as delivery vehicles for mediating intracellular uptake of therapeutic payloads. Another significant patent is "Accessory factory function for interferon gamma and its receptor." This invention relates to a 540 kb YAC that encodes necessary species-specific factors, which can substitute for human Chromosome 21 to reconstitute the Hu-IFN-gamma receptor-mediated induction of class I HLA antigens. It also involves the construction of a plasmid for integrating selective markers and the development of fragmentation vectors for targeting yeast artificial chromosomes containing human genomic DNA.

Career Highlights

Robert J Donnelly is affiliated with the University of Medicine and Dentistry of New Jersey, where he has been able to leverage his expertise in biotechnology. His work has contributed to advancements in understanding and manipulating genetic materials for therapeutic purposes.

Collaborations

Donnelly has collaborated with notable figures in the field, including Sidney Pestka and Serguei V Kotenko. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Robert J Donnelly's innovative work in biotechnology, particularly in cell-penetrating peptides and genetic manipulation, showcases his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving therapeutic delivery systems.